AI assistant
HERAMED LIMITED — Share Issue/Capital Change 2020
Aug 13, 2020
65062_rns_2020-08-13_c391d4c1-7d90-4a27-8863-d5e4d013b704.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
HERAMED LIMITED
Announcement Type
New announcement
Date of this announcement
Friday August 14, 2020
The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A placement or other type of issue
Total number of +securities proposed to be issued for a placement or other type of issue
Maximum Number of ASX +security code +Security description +securities to be issued n/a Performance Options 5,500,000
Proposed +issue date
Friday August 14, 2020
Refer to next page for full details of the announcement
Proposed issue of securities
1 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of +Entity
HERAMED LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
1.2 Registered Number Type
ACN
Registration Number
626295314
1.3 ASX issuer code
HMD
1.4 The announcement is
==> picture [8 x 9] intentionally omitted <==
New announcement
1.5 Date of this announcement
Friday August 14, 2020
1.6 The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A placement or other type of issue
Proposed issue of securities
2 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 - Are any of the following approvals required for the placement or other type of issue? +Security holder approval Court approval Lodgement of court order with +ASIC ACCC approval FIRB approval Another approval/condition external to the entity
==> picture [8 x 8] intentionally omitted <==
No
Part 7B - Issue details
Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? New class
Details of +securities proposed to be issued
ISIN Code (if Issuer is a foreign company and +securities are non CDIs)
Have you received confirmation from Will the entity be seeking quotation ASX that the terms of the proposed of the 'new' class of +securities on +securities are appropriate and ASX? equitable under listing rule 6.1? No Yes ASX +security code +Security description New class-code to be confirmed Performance Options
+Security type
Performance options/rights
Number of +securities proposed to be issued
5,500,000
Offer price details
Proposed issue of securities
3 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Are the +securities proposed to be issued being issued for a cash consideration? No
Please describe the consideration being provided for the +securities
Agreement with Freeman Road and PHI Group to design, arrange and lead clinical pilot projects and clinical studies for HeraBEAT and HeraCARE. For more information please refer to the announcement on 20 May 2020 and the notice of annual general meeting released 12 June 2020.
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 180,400.000000 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes
Performance options/rights details
+Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.1500 Sunday August 14, 2022 Details of the type of +security that will be issued if the option is exercised HMD : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised 5,500,000
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. https://www.asx.com.au/asxpdf/20200612/pdf/44jlmx8lgykml8.pdf
Part 7C - Timetable
7C.1 Proposed +issue date
Friday August 14, 2020
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? Yes
Proposed issue of securities
4 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1
Tuesday July 14, 2020
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue? No
7E.2 Is the proposed issue to be underwritten? No
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Under the terms of agreement with Freeman Road announced on 20 May 2020, 5,500,000 performance options are to be issued exercisable on different milestones.
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No
7F.2 Any other information the entity wishes to provide about the proposed issue
Proposed issue of securities
5 / 5